Fabrication and Use of Dry Macroporous Alginate Scaffolds for Viral Transduction of T Cells

作者： Madelyn VanBlunk1, Pritha Agarwalla1,2, Sharda Pandit1,2, Yevgeny Brudno1,2,3 1Joint Department of Biomedical Engineering,University of North Carolina at Chapel Hill and North Carolina State University, 2Comparative Medicine Institute,North Carolina State University, 3Lineberger Comprehensive Cancer Center,University of North Carolina at Chapel Hill

简介：

Overview

This article presents a protocol for creating dry macroporous alginate scaffolds, known as Drydux, which facilitate efficient viral gene transfer in T cells. The method offers a simpler and more cost-effective alternative to traditional transduction techniques.

Key Study Components

Area of Science

• Genetic engineering
• T cell therapy
• Viral transduction

Background

• Traditional methods for T cell transduction can be complex and costly.
• Drydux scaffolds provide a novel approach to enhance transduction efficiency.
• Efficient gene transfer is crucial for advancements in CAR-T cell therapy.
• Comparative studies show Drydux's effectiveness against standard methods.

Purpose of Study

• To develop a protocol for using Drydux scaffolds in T cell transduction.
• To evaluate the transduction efficiency of Drydux compared to conventional methods.
• To simplify the process of genetic engineering in T cells.

Methods Used

• Preparation of a 0.4% solution of calcium-D-gluconate.
• Dissolving calcium-D-gluconate in sterile filtered DI water.
• Stirring the solution for approximately 1.5 hours.
• Using Drydux scaffolds for T cell transduction experiments.

Main Results

• Drydux scaffolds achieved >85% transduction efficiency in activated primary T cells.
• Results were comparable to those obtained using RetroNectin-coated plates.
• Drydux serves as a cheaper and more convenient alternative.
• The protocol simplifies the transduction process significantly.

Conclusions

• Drydux scaffolds are effective for viral gene transfer in T cells.
• This method can enhance CAR-T cell therapy applications.
• Future studies may explore further optimization of the protocol.

Frequently Asked Questions